Gold slips as equities hit record on optimism over virus treatment

Reuters

Published Aug 25, 2020 01:13

Updated Aug 25, 2020 04:48

Gold slips as equities hit record on optimism over virus treatment

* S&P 500 and Nasdaq scale record levels

* Investors eye Fed Chair's address at Jackson Hole this week

* Interactive graphic tracking global spread of coronavirus: open https://tmsnrt.rs/3aIRuz7 in an external browser (Updates prices)

By Sumita Layek

Aug 24 (Reuters) - Gold prices fell on Monday as optimism over a U.S. health regulator's authorization of a COVID-19 treatment lifted Wall Street stocks to record highs.

Spot gold XAU= fell 0.5% to $1,929.12 an ounce by 2:35 p.m. EDT (1835 GMT), having jumped 1% to $1,961.40. U.S. gold futures GCv1 settled down 0.4% at $1,939.20.

"Gold is just consolidating right now with stock indexes at record highs. It really needs a bigger catalyst, it needs additional fiscal stimulus, it needs inflation to pick up, in order to get really going," said Phillip Streible, chief market strategist at Blue Line Futures in Chicago.

The S&P 500 and Nasdaq hit record highs after the U.S. Food and Drug Administration approved the emergency use of blood plasma in COVID-19 patients and on a report the Trump administration may fast-track a vaccine candidate. .N talks between top Democrats and Republicans on coronavirus aid legislation remained stalled. COVID-19 vaccine developments and improving economic data present near-term headwinds to gold, low and negative interest rates, a weaker U.S. dollar, and expectations for further stimulus keep the balance of risks to the upside," said Standard Chartered (LON:STAN) analyst Suki Cooper in a note.

Central banks worldwide have rolled out massive stimulus measures to alleviate the economic damage caused by the COVID-19 pandemic, but that has also increased the probability of rising inflation.

Investors are awaiting U.S. Federal Reserve Chair Jerome Powell's address to the bank's annual symposium in Jackson Hole, Wyoming, on Thursday for signs of how aggressively it will seek to handle the long-term recovery from the pandemic. other metals, silver XAG= fell 0.9% to $26.43 an ounce, platinum XPT= was down 0.5% at $914.22 and palladium XPD= eased 1.2% to $2,155.90.

Get The App
Join the millions of people who stay on top of global financial markets with Investing.com.
Download Now

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes